Work

A phase II study of sunitinib on a continuous dosing schedule in patients (pts) with relapsed or refractory urothelial carcinoma (UC)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.5072

Authors: D. J. Gallagher, M. I. Milowsky, S. R. Gerst, S. Tickoo, N. Ishill, N. Ishill, A. Regazzi, A. Trout, D. F. Bajorin

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242428384

Cites:

Cited by: 8

Related to: 10